Monday, Jul 8, 2024 · SEC filings
What the smart money revealed on Jul 8
314 insider filings came in. We hid 53 planned (10b5-1) sellers and 204 people whose filings were routine, like grants and tax withholding.
Global Acquisitions (AASP) President Ronald Boreta bought $598K
1.5M shares on the open market. Not a grant or an option exercise.
Global Acquisitions (AASP) Director John Boreta bought $598K
1.5M shares on the open market. Not a grant or an option exercise.
Tempest Therapeutics (TPST) President and CEO Stephen Brady bought $73.8K
35,000 shares on the open market. Not a grant or an option exercise.
Bicycle Therapeutics (BCYC) CEO Kevin Lee sold $62.7K
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 384,076 shares.
Joby Aviation (JOBY) Officer Matthew Field sold $60.8K
Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 299,880 shares.
G1 Therapeutics (GTHX) President and CEO John Bailey Jr. sold $19.2K
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 549,674 shares.
Show 14 more real buys
Show 20 more real sales
13F season
Holdings as of Jun 30, 2024 are due Aug 14
54 funds have filed so far. 50 filed for the quarter before.
Biggest real insider buys, Jul 2–8
Open-market buys by officers and directors, filed in the 7 days up to Jul 8.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.